+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anterior Uveitis Treatment Market Research Report by Treatment Type, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5292910
  • Report
  • February 2021
  • Region: Global
  • 180 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
The Global Anterior Uveitis Treatment Market to Grow USD 289.82 Million by 2025, at a CAGR of 7.53%

FEATURED COMPANIES

  • AbbVie Inc.
  • Akorn Pvt. Ltd
  • Amgen Inc.
  • Hanall Biopharma
  • Novartis AG
  • Sirion Therapeutics, Inc.
Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Anterior Uveitis Treatment Market is expected to grow from USD 201.59 Million in 2020 to USD 289.82 Million by the end of 2025.
2. The Global Anterior Uveitis Treatment Market is expected to grow from EUR 176.75 Million in 2020 to EUR 254.11 Million by the end of 2025.
3. The Global Anterior Uveitis Treatment Market is expected to grow from GBP 157.13 Million in 2020 to GBP 225.91 Million by the end of 2025.
4. The Global Anterior Uveitis Treatment Market is expected to grow from JPY 21,514.76 Million in 2020 to JPY 30,931.13 Million by the end of 2025.
5. The Global Anterior Uveitis Treatment Market is expected to grow from AUD 292.73 Million in 2020 to AUD 420.85 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Anterior Uveitis Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Treatment Type, the Anterior Uveitis Treatment Market is examined across Anti-TNF Agents, Corticosteroids, Cycloplegic Agents, and Immunosuppressants.
  • Based on Distribution Channel , the Anterior Uveitis Treatment Market is examined across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Geography, the Anterior Uveitis Treatment Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Anterior Uveitis Treatment Market including AbbVie Inc., Aciont Inc., Akorn Pvt. Ltd, Aldeyra Therapeutics, Inc., Alimera Sciences Inc., Amdipharm Mercury Company Limited, Amgen Inc., Bausch & Lomb Incorporated, Clearside Biomedical, Inc., Enzo Biochem Inc, Enzo Biochem Inc., Eyegate Pharmaceuticals, Inc., Hanall Biopharma, Lux Biosciences, Inc, Novartis AG, Ophthalix Inc, Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co. Ltd, Sirion Therapeutics, Inc., TopiVert Pharma Limited, UAB Medicine, UCB Biopharma S.P.R.L., Wize Pharma Inc, and Xoma Corporation.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. The ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anterior Uveitis Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Anterior Uveitis Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anterior Uveitis Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anterior Uveitis Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Anterior Uveitis Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Anterior Uveitis Treatment Market?
6. What are the modes and strategic moves considered suitable for entering the Global Anterior Uveitis Treatment Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Akorn Pvt. Ltd
  • Amgen Inc.
  • Hanall Biopharma
  • Novartis AG
  • Sirion Therapeutics, Inc.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Treatment Type Outlook
3.4. Distribution Channel Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of eye infections
5.1.1.2. Rising expenditure on the research and development of novel drugs and treatments for Uveitis
5.1.2. Restraints
5.1.2.1. High cost associated with the medications
5.1.2.2. Limited knowledge about eye disorders
5.1.3. Opportunities
5.1.3.1. Development of research companies on biological drugs
5.1.3.2. Growing demand for drugs such as corticosteroids and anti-inflammatory medications in developing countries
5.1.4. Challenges
5.1.4.1. Side effect associated with corticosteroid treatment
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Anterior Uveitis Treatment Market, By Treatment Type
6.1. Introduction
6.2. Anti-TNF Agents
6.3. Corticosteroids
6.4. Cycloplegic Agents
6.5. Immunosuppressants

7. Global Anterior Uveitis Treatment Market, By Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Pharmacies
7.4. Retail Pharmacies

8. Americas Anterior Uveitis Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Anterior Uveitis Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand

10. Europe, Middle East & Africa Anterior Uveitis Treatment Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. AbbVie Inc.
12.2. Aciont Inc.
12.3. Akorn Pvt. Ltd
12.4. Aldeyra Therapeutics, Inc.
12.5. Alimera Sciences Inc.
12.6. Amdipharm Mercury Company Limited
12.7. Amgen Inc.
12.8. Bausch & Lomb Incorporated
12.9. Clearside Biomedical, Inc.
12.10. Enzo Biochem Inc
12.11. Enzo Biochem Inc.
12.12. Eyegate Pharmaceuticals, Inc.
12.13. Hanall Biopharma
12.14. Lux Biosciences, Inc
12.15. Novartis AG
12.16. Ophthalix Inc
12.17. Regeneron Pharmaceuticals, Inc.
12.18. Santen Pharmaceutical Co., Ltd.
12.19. Senju Pharmaceutical Co. Ltd
12.20. Sirion Therapeutics, Inc.
12.21. TopiVert Pharma Limited
12.22. UAB Medicine
12.23. UCB Biopharma S.P.R.L.
12.24. Wize Pharma Inc
12.25. Xoma Corporation

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
Figure 1. Global Anterior Uveitis Treatment Market: Research Process
Figure 2. Global Anterior Uveitis Treatment Market: Research Execution
Figure 3. Global Anterior Uveitis Treatment Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Anterior Uveitis Treatment Market Size, by Treatment Type, 2020 (USD Million)
Figure 5. Global Anterior Uveitis Treatment Market Size, by Distribution Channel , 2020 (USD Million)
Figure 6. Global Anterior Uveitis Treatment Market Size, by Geography, 2020 (USD Million)
Figure 7. Global Anterior Uveitis Treatment Market Size, 2018-2025 (USD Million)
Figure 8. Global Anterior Uveitis Treatment Market Size, by Geography, 2020 Vs 2025 (%)
Figure 9. Global Anterior Uveitis Treatment Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 10. Competitive Strategic Window for Global Anterior Uveitis Treatment Market Size, by Geography, 2025
Figure 11. Global Anterior Uveitis Treatment Market: Market Dynamics
Figure 12. Global Anterior Uveitis Treatment Market: Porters Five Forces Analysis
Figure 13. Global Anterior Uveitis Treatment Market Size, by Treatment Type, 2020 Vs 2025 (%)
Figure 14. Global Anterior Uveitis Treatment Market Size, by Treatment Type, 2020 Vs 2025 (USD Million)
Figure 15. Competitive Strategic Window for Global Anterior Uveitis Treatment Market Size, by Treatment Type, 2025
Figure 16. Global Anterior Uveitis Treatment Market Size, by Anti-Tnf Agents, 2020 Vs 2025 (USD Million)
Figure 17. Global Anterior Uveitis Treatment Market Size, by Corticosteroids, 2020 Vs 2025 (USD Million)
Figure 18. Global Anterior Uveitis Treatment Market Size, by Cycloplegic Agents, 2020 Vs 2025 (USD Million)
Figure 19. Global Anterior Uveitis Treatment Market Size, by Immunosuppressants, 2020 Vs 2025 (USD Million)
Figure 20. Global Anterior Uveitis Treatment Market Size, by Distribution Channel , 2020 Vs 2025 (%)
Figure 21. Global Anterior Uveitis Treatment Market Size, by Distribution Channel , 2020 Vs 2025 (USD Million)
Figure 22. Competitive Strategic Window for Global Anterior Uveitis Treatment Market Size, by Distribution Channel , 2025
Figure 23. Global Anterior Uveitis Treatment Market Size, by Hospital Pharmacies, 2020 Vs 2025 (USD Million)
Figure 24. Global Anterior Uveitis Treatment Market Size, by Online Pharmacies, 2020 Vs 2025 (USD Million)
Figure 25. Global Anterior Uveitis Treatment Market Size, by Retail Pharmacies, 2020 Vs 2025 (USD Million)
Figure 26. Americas Anterior Uveitis Treatment Market Size, by Geography, 2020 Vs 2025 (%)
Figure 27. Americas Anterior Uveitis Treatment Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 28. Competitive Strategic Window for Americas Anterior Uveitis Treatment Market Size, by Geography, 2025
Figure 29. Argentina Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 30. Brazil Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 31. Canada Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 32. Mexico Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 33. United States Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 34. Asia-Pacific Anterior Uveitis Treatment Market Size, by Geography, 2020 Vs 2025 (%)
Figure 35. Asia-Pacific Anterior Uveitis Treatment Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 36. Competitive Strategic Window for Asia-Pacific Anterior Uveitis Treatment Market Size, by Geography, 2025
Figure 37. Australia Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 38. China Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 39. India Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 40. Indonesia Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 41. Japan Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 42. Malaysia Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 43. Philippines Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 44. South Korea Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 45. Thailand Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 46. Europe, Middle East & Africa Anterior Uveitis Treatment Market Size, by Geography, 2020 Vs 2025 (%)
Figure 47. Europe, Middle East & Africa Anterior Uveitis Treatment Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 48. Competitive Strategic Window for Europe, Middle East & Africa Anterior Uveitis Treatment Market Size, by Geography, 2025
Figure 49. France Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. Germany Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. Italy Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. Netherlands Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. Qatar Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 54. Russia Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 55. Saudi Arabia Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 56. South Africa Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 57. Spain Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 58. United Arab Emirates Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 59. United Kingdom Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 60. Global Anterior Uveitis Treatment Market: Fpnv Positioning Matrix
Figure 61. Global Anterior Uveitis Treatment Market: Market Share Analysis
Figure 62. Global Anterior Uveitis Treatment Market: Competitor SWOT Analysis
Figure 63. Competitive Scenario Analysis in Global Anterior Uveitis Treatment Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Anterior Uveitis Treatment Market Size, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 3. Global Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 4. Global Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 5. Global Anterior Uveitis Treatment Market Size, by Anti-Tnf Agents, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 6. Global Anterior Uveitis Treatment Market Size, by Corticosteroids, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 7. Global Anterior Uveitis Treatment Market Size, by Cycloplegic Agents, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 8. Global Anterior Uveitis Treatment Market Size, by Immunosuppressants, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 9. Global Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 10. Global Anterior Uveitis Treatment Market Size, by Hospital Pharmacies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 11. Global Anterior Uveitis Treatment Market Size, by Online Pharmacies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 12. Global Anterior Uveitis Treatment Market Size, by Retail Pharmacies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 13. Americas Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 14. Americas Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 15. Americas Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 16. Argentina Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 17. Argentina Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 18. Brazil Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 19. Brazil Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 20. Canada Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 21. Canada Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 22. Mexico Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 23. Mexico Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 24. United States Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 25. United States Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 26. Asia-Pacific Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 27. Asia-Pacific Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 28. Asia-Pacific Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 29. Australia Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 30. Australia Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 31. China Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 32. China Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 33. India Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 34. India Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 35. Indonesia Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 36. Indonesia Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 37. Japan Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 38. Japan Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 39. Malaysia Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 40. Malaysia Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 41. Philippines Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 42. Philippines Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 43. South Korea Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 44. South Korea Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 45. Thailand Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 46. Thailand Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 47. Europe, Middle East & Africa Anterior Uveitis Treatment Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 48. Europe, Middle East & Africa Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 49. Europe, Middle East & Africa Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 50. France Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 51. France Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 52. Germany Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 53. Germany Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 54. Italy Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 55. Italy Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 56. Netherlands Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 57. Netherlands Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 58. Qatar Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 59. Qatar Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 60. Russia Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 61. Russia Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 62. Saudi Arabia Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 63. Saudi Arabia Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 64. South Africa Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 65. South Africa Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 66. Spain Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 67. Spain Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 68. United Arab Emirates Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 69. United Arab Emirates Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 70. United Kingdom Anterior Uveitis Treatment Market Size, by Treatment Type, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 71. United Kingdom Anterior Uveitis Treatment Market Size, by Distribution Channel , 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 72. Global Anterior Uveitis Treatment Market: Scores
Table 73. Global Anterior Uveitis Treatment Market: Business Strategy
Table 74. Global Anterior Uveitis Treatment Market: Product Satisfaction
Table 75. Global Anterior Uveitis Treatment Market: Ranking
Table 76. Global Anterior Uveitis Treatment Market: Merger & Acquisition
Table 77. Global Anterior Uveitis Treatment Market: Agreement, Collaboration, & Partnership
Table 78. Global Anterior Uveitis Treatment Market: New Product Launch & Enhancement
Table 79. Global Anterior Uveitis Treatment Market: Investment & Funding
Table 80. Global Anterior Uveitis Treatment Market: Award, Recognition, & Expansion
Table 81. Global Anterior Uveitis Treatment Market: License & Pricing
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Aciont Inc.
  • Akorn Pvt. Ltd
  • Aldeyra Therapeutics, Inc.
  • Alimera Sciences Inc.
  • Amdipharm Mercury Company Limited
  • Amgen Inc.
  • Bausch & Lomb Incorporated
  • Clearside Biomedical, Inc.
  • Enzo Biochem Inc
  • Eyegate Pharmaceuticals, Inc.
  • Hanall Biopharma
  • Lux Biosciences, Inc
  • Novartis AG
  • Ophthalix Inc
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Senju Pharmaceutical Co. Ltd
  • Sirion Therapeutics, Inc.
  • TopiVert Pharma Limited
  • UAB Medicine
  • UCB Biopharma S.P.R.L.
  • Wize Pharma Inc
  • Xoma Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll